blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1



Monday, 24 January 2011

Disability rights campaigners protested today outside the London HQ of Atos Origin against the punitive medical testing of those claiming disability and sickness benefits. London, United Kingdom. 24/01/2011




Disability rights campaigners protested today outside the London HQ of Atos Origin against the punitive medical testing of those claiming disability and sickness benefits. London, United Kingdom. 24/01/2011


read on -


 
 
 
http://www.demotix.com/news/567201/disability-rights-campaigners-protest-outside-atos-origin-hq

DWP Publish Secret Atos Origin Advice Lines

DWP Publish Secret Atos Origin Advice Lines


January 23, 2011

tags: Atos Origin, DWP, National Day of Protest Against Benefit Cuts, troll a toryby benefitclaimantsfightback

.As well as Trolling Tories tomorrow why not give Atos a call. Here’s the phone numbers they didn’t want you to see taken straight from: http://www.dwp.gov.uk/healthcare-professional/guidance/atos-healthcare/



“Advice from Atos



Atos Healthcare can give telephone advice to clinicians on medical matters relating to:



certification – such as completion of certificates and reports

disability benefits.

They are only able to offer general advice and cannot discuss individual cases of people who are being assessed for benefit. This advice service is strictly for healthcare professionals.



Atos Healthcare can also provide more formal educational sessions to clinicians by prior arrangement.

Atos help lines for clinicians



Please do not give these numbers to patients.




Birmingham 0121 626 2941

Bootle 0151 934 6070

Bristol 0117 971 8382

Cardiff 029 2058 6750

Croydon 0208 633 1324

Edinburgh 0131 222 5055

Glasgow 0141 249 3616

Leeds 0113 230 9068

Manchester 0121 335 0720

Newcastle 01264 837 789

Nottingham 0115 975 8362

Wembley 0208 795 8772″



.

Sir Gordon Duff v Mark Harvey .... who is telling porkies & why?


Sir Gordon Duff (Florey professor of molecular medicine at Sheffield University) said -

Like Seroxat and Efexor, none of these drugs has ever been licensed for use in those under 18

where did he say it -
http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045












Mark Harvey (class action lawyer) said -


"
....during the year the Users Group and I have orchestrated the campaign against the drug and we have obtained the following victories:-

a) The institution of a Government review into Seroxat; (this has already worked one triumph, a press and public announcement of the dangers of the drug with suicide and the ban of its prescription to minors)

"

https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhrij8qx83ZrVq5-uR7h7haP2XGkN87I6_L2z_qADXFwviUu6ijkkgbfruNf8SYKbVKGqD4Y2JZQqkMAJyqUlTXJNm1Nv7Sol0rWx2WCS9BvYSE8KAG6vaklPp01w6PNPZEll4O-v_bGQ0/s1600/my+clients.jpg


Stop SSRI / SNRI lies - but beware of causes that support Seroxat liars !

Stop SSRI / SNRI lies - but beware of causes that support Seroxat liars !


Seroxat has never been licensed for use in those under 18 - anyone who said it was banned, is a LIAR

Press release Date: 10 Dec 2003


Subject: Safety review of antidepressants used by children completed (reference 2003/0505)

Contact: Press Office 020 3080 7651

or press.office@mhra.gsi.gov.uk

Out-of-hours 07770 446 189



Professor Gordon Duff, Chairman of the Committee on Safety of Medicines, said:


"The CSM Expert Group has delivered comprehensive advice on the use of these drugs in children and young people following a thorough review of all the evidence available. This gives parents, young people and those who treat these devastating illnesses the information they need to make informed decisions about treatment."



"Like Seroxat and Efexor, none of these drugs has ever been licensed for use in those under 18."




"We know, however, they are used in this age group outside of their licensed indications where prescribers make a judgement on their own responsibility that it is the correct treatment for a particular patient.



"It is therefore important that patients, parents and doctors are aware of the new advice. Young people with depressive illness currently taking any SSRI other than fluoxetine should not stop taking their medicine but should consult their doctor for advice on treatment".


http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045









SSRI - SNRI : UK regulators position for use in children. (source MHRA)

Sunday, 23 January 2011

Pharma sued by 23,600 persons over 30 years NO case went to trial !

(The only winners, it seems, are the fat cat lawyers)




here is an Atypical fat cat 
but there are many others







"
In a succession of major English cases from the mid 1970’s, a total of around 23,600 claimants brought claims in a succession of multiparty claims against manufacturers involving DTP vaccine, Opren, Myodil contrast media, benzodiazepine tranqullizers and the Norplant subcutaneous contraceptive (Hodges, 1999). However, no case proceeded as far as a final trial on liability. The failure of the DTP vaccine, tranquillizer and Norplant litigation in the UK can be contrasted with the fact that the manufacturers settled similar claims in the USA at enormous cost in order to avoid even greater costs of years of litigation. In 2000, a case was heard relating to the failure of a condom resulting in pregnancy, but the judge held that the defendant’s in the case had never claimed that a condom was 100% effective, and therefore the claim failed. "

1 In March 2001, the first ever successful UK product-related class action (

source - http://www.ippa.ws/IPPC1/BOOK/Chapter_15.pdf
A v National Blood Authority [2001] 3 All E.R. 289) under the Consumer Protection Act strict liability was decided, when six test cases (representing a total of 114 claimants) obtained awards of up to £210,000 from Hepatitis C infection from NHS blood transfusions. Goldberg (2002) notes the implications of this case, as it was the first opportunity of its kind in the UK to assess the problem of strict medicinal product liability in the context of a multi-party action.2

UK solicitors has set up the "Seroxat Users Group"

THE IMPACT OF PRODUCT LIABILITY LEGISLATION ON THE PROCUREMENT OF PHARMACEUTICALS WITHIN HPSS TRUSTS IN NORTHERN IRELAND

Ruth Fee and Jill Mairs
http://www.ippa.ws/IPPC1/BOOK/Chapter_15.pdf


extract -


A further indication of the consumer expectation approach in the European Union was evidenced by the case of Scholten v Foundation Sanquin of Blood Supply [1999] H/98.0896, County Court of Amsterdam. The claimant received an HIV infected blood transfusion from a donor. The Court held that the blood product was defective because the general public expected that blood products in the Netherlands had been one hundred per cent HIV free for some time. In contrast, the UK High Court has recently thrown out the case against Schering, Organon and Wyeth based on research finding in 1995 that the so-called third generation oral contraceptives (OC) posed a greater risk from venous thrombosis than the second generation (XYZ v Schering Health Care Ltd [2002] EWHC 1420 (QB). The court found, having carried out a "most exhaustive examination" that there was no such increased risk (PharmaLaw Newsletter, 2002). However, the OC case has not deterred new claims; for example, a firm of UK solicitors has set up the "Seroxat Users Group" for patients who receive the antidepressant alleging links between the product and suicide, addiction and aggression.
Copyright © 2005 by PrAcademics Press

SSRI suicide drug payouts in USA, but not in UK, where Celexa/Cipramil is biggest seller

                          extract -
Fifty-four lawsuits, mostly involving suicides and attempted suicides by teenagers in various parts of the country, accuse the New York-based pharmaceutical company of concealing a negative pediatric study on Celexa, duping physicians about the drug's clinical trials, and targeting children in aggressive promotions of Celexa and a sister drug, Lexapro.



more -


Details of Forest Laboratories' monetary settlements with aggrieved families have not been made public, but the lawsuits themselves present a glimpse of the alleged harm caused by the company, including hefty payments to pediatricians and other physicians to tout the benefits of the drugs.


see also -


A case settled Friday was on behalf of Alex Kim of Gwinnett County, Ga., who hanged himself in June 2004 when he was 13 after his Lexapro dosage had been doubled. He had been taking the drug for about three months.




In their lawsuit, Alex's parents asked for $10 million in general damages, plus $10 million in punitive damages from Forest for "failing to provide information regarding serious health risks, failing to publicize the risks, failing to timely alert the public, and failing to recall the product."

http://www.stltoday.com/business/article_c569f2c4-58a7-5432-a939-ff22e90583e5.html




............so why no payouts in UK where Cipramil now has over 30% of the market?

.............who failed the UK Cipramil suicide victims?





Celexa (cipramil) Lexapro settling suits over drugs tied to suicides - (repost)

Celexa (cipramil) Lexapro settling suits over drugs tied to suicides


http://www.stltoday.com/business/article_c569f2c4-58a7-5432-a939-ff22e90583e5.html





PROZAC in Fish linked to FILTHY Canadian sewer engineering

"Montreal has a very basic sewage system–the city basically only removes solids, there's no disinfecting of the water," Sauvé explains. "

 no immediate danger to humans. "The amount of antidepressants being released into our river works out to roughly the equivalent of a grain of salt in an Olympic-size swimming pool,"


St. Lawrence: A Prozac Nation for Fish?




http://watercanada.net/2011/st-lawrence-a-prozac-nation-for-fish/



A sewage treatment plant in Montreal. Credit: University of Montreal.




Around one in four Montrealers take some kind of antidepressant, and according to new research, the drugs are passing into the waterways and affecting fish.



Led by Dr. Sébastien Sauvé and PhD candidate André Lajeunesse, a University of Montreal research team has found that the drugs accumulate in fish tissues and are affecting brain activity. Sauvé has also been involved in studies on antibiotics and chemicals in waterways.



"Montreal has a very basic sewage system–the city basically only removes solids, there's no disinfecting of the water," Sauvé explains. "In any case, the chemical structure of antidepressants makes them extremely difficult to remove from sewage, even with the most sophisticated systems available."



"We know that antidepressants have negative side effects on human beings," Sauvé says, "but we don't know how exactly how these chemicals are affecting the fish, and by extension, the St. Lawrence River's ecosystem." Despite a lack of information about the possible toxicity resulting from these substances, the research group suggests an interesting tool to track the early biological effects of antidepressants.



"Since the acute toxicity of antidepressants is less probable toward aquatic organisms, chronic toxicity remained possible. In this way, the suggested biomarker involved in the serotonin regulation in the brain may represent a promising means of determining subtle biological effects to fish," explains Lajeunesse. Chronic toxicity means harm resulting from long-term exposure, whereas acute relates to more immediate harm following a single high-dose incident.



Sauvé says there is no immediate danger to humans. "The amount of antidepressants being released into our river works out to roughly the equivalent of a grain of salt in an Olympic-size swimming pool," he says. "That's not enough to affect people, should they are brave enough to go fishing out there–I'd be more worried about the trace metals. Nevertheless, we are seeing an impact on the river's ecosystem, which should concern cities everywhere."



This research received funding from the Chemical Management Plan – Health Canada, the St. Lawrence Action Plan and the Canadian Foundation for Innovation. The study was published online by Chemosphere on January 5







Fiddy on The Roof - If I were a rich man (with subtitles)





Saturday, 22 January 2011

Possible legal action – Quote from 10 years ago show most fail

But group actions face particular problems in Britain. Attempts to litigate against the makers of benzodiazapines – including Valium, Librium and Ativan, which were also said not to be addictive when they were launched – collapsed because the legal aid granted to the claimants was used up in the lengthy investigations of the cases demanded by the companies before the action reached court.

http://www.guardian.co.uk/uk/2001/dec/10/medicalscience.highereducation

•Sarah Boseley, health editor


•The Guardian, Monday 10 December 2001 10.15 GMT

More than 60 people in Britain who say they have become hooked on the anti-depressant Seroxat – a drug in the Prozac class – are exploring the possibility of legal action against the pharmaceutical company which they claim failed to warn doctors that that it could create dependency.



Two firms of solicitors say they already have between 30 and 40 cases each. The people have come forward following news of a legal case in the US in which 35 people allege they suffered severe side-effects when they tried to stop taking the drug.



The Los Angeles law firm Baum, Hedlund, Aristei, Guilford and Schiavo – which filed its action against the British manufacturers GlaxoSmithKline in September – has since had more than 2,000 calls from people to tell of their addiction to the drug, which is known in the US as Paxil. The side-effects they suffer when they try to stop taking the tablets, include jolting pains in the head, vertigo, loss of coordination, abdominal discomfort, agitation and confusion.



The US lawyers have asked GSK to set up treatment centres to help people attempting to withdraw from Paxil/Seroxat. GSK say there is no reliable scientific evidence that the drug causes addiction or dependency.



The British solicitors, Ross & Co, based in the Wirral, and Hugh James Ford Simey of Cardiff, have been receiving calls from people who did not realise that others had suffered the same symptoms when they tried to cut down and come off the drug.



“We have been contacted by 30 to 40 people, most of whom have startlingly similar tales to tell of being put on the drug and being taken off it, and then going back on,” said Mark Harvey of Hugh James Ford Simey.



Mr Harvey said most people are told by the doctor that their problems are the symptoms of their depression re-appearing and do not suspect that the drug might be to blame. “This does have the smell of something that is a problem,” he said. “The patient information sheet says it is not addictive twice.”



Graham Ross, of Ross & Co, thinks that there is a good potential case against the manufacturers. “So far as evidence of dependency is concerned, that is pretty strong,” he said.



“I feel we can prove that. Failure to ensure that GPs are aware of that risk and therefore warn patients accordingly – there is plenty of evidence that they are not doing that.”



But group actions face particular problems in Britain. Attempts to litigate against the makers of benzodiazapines – including Valium, Librium and Ativan, which were also said not to be addictive when they were launched – collapsed because the legal aid granted to the claimants was used up in the lengthy investigations of the cases demanded by the companies before the action reached court.





DrWakefield (Andy Wakefield) patented vaccine to replace the MMR he hoped to discredit

MHRA Communication Strategy 2010 - 2015

We are pleased to announce the launch of our third Communication Strategy.


This strategy builds on the solid foundations laid by the previous two but this time sets out the importance of careful prioritisation and selection of activities, particularly in terms of what the Agency can help to deliver within the current and future funding constraints.

We have set a clear and ambitious vision for the future with aims that are both deliverable and measurable, while aligned to our business outcomes and priorities.

This strategy recognises the importance of continuing to maintain relationships built up over previous years. However, this time it identifies the public as our primary stakeholder on the basis that it is them to whom our business belongs, and on whose behalf we work and regulate.

It is, however, recognised that the public makes for a large and diverse audience. Although the MHRA will continue to engage and communicate with as many public stakeholder groups as is practically possible, we also acknowledge we cannot do this all on our own.

So we have identified three additional priority stakeholder groups we hope will help us to deliver our service to the public: healthcare professionals, industry and our own staff.



MHRA Communication Strategy 2010 - 2015 (92Kb)







one person we won't be talking to is self styled patient advocate Bobby Fiddaman

Fish, Chips...and Prozac - CCHR seriously misrepresent study

Fish, Chips...and Prozac!

CCHR seriously misrepresent study


NOTE - Sauvé said such drugs as chemotherapy medicines, hormones and antibiotics have been found in fish and pose a greater danger to human health than antidepressants.

ALSO - the study is a result of a controlled experiment. How much antidepressant medication is in fish in the river will vary greatly, depending on the kind of fish and its habitat.

http://www.cchrint.org/2011/01/21/river-fish-loaded-with-prozac-study/






"Am I a Commissioner for CCHR? No, but I sure would like to be. They are at the forefront of raising awareness about this fraudulent industry and if that means someone labelling me a Scientologist then that is a very small price to pay for someone else's ignorance"


Seroxat liar - Hugh James solicitor claimed it was banned for minors

What did he say?


"

....during the year the Users Group and I have orchestrated the campaign against the  drug and we have obtained the following victories:-

a) The institution of a Government review into Seroxat; (this has already worked one triumph, a press and public announcement of the dangers of the drug with suicide and the ban of its prescription to minors)

"

 
 
 
 
 
 
 
 
 
 
 
 
Where did he say it ?
 
 
 
 
 
 
 
 
& the TRUTH is ?
 
 
extract (click below to enlarge)





http://the-uk-seroxat-litigation-chronicles.blogspot.com/2010/12/seroxat-litigation-report-of-committee.html